Experts Slam Regulators Over Blocked Alzheimer's Treatments

Experts are calling on ministers to provide funding for novel Alzheimer's treatments, expressing dismay over regulatory bodies preventing access to a drug designed to slow the disease's progression. This advocacy follows a significant achievement by the NHS, which has finally met its dementia diagnosis target.

For the first time since March 2020, the health service has reached its goal for diagnosing dementia. However, this milestone is overshadowed by the lack of widely available treatments that can halt or reverse the advancement of Alzheimer's disease, despite the existence of promising drug therapies.